1. Neurotoxicity

   Newsletter Article 04 February 2013 Pages: 1 - 2

2. Sclerosing peritonitis following propranolol was unlikely to have been a ‘practolol syndrome’

   Newsletter Article 04 February 2013 Pages: 2 - 2

3. Retroperitoneal fibrosis with atenolol

   Newsletter Article 04 February 2013 Pages: 2 - 2

4. Vincristine overdose

   Newsletter Article 04 February 2013 Pages: 2 - 2

5. Doxorubicin cardiotoxicity evaluated in children

   Newsletter Article 04 February 2013 Pages: 2 - 2

6. Acetaminophen interaction?

   Newsletter Article 04 February 2013 Pages: 3 - 3

7. Alfacalcidol

   Newsletter Article 04 February 2013 Pages: 3 - 3

8. Allopurinol

   Newsletter Article 04 February 2013 Pages: 3 - 3

9. Allopurinol interaction

   Newsletter Article 04 February 2013 Pages: 3 - 3

10. Aminopyrine

    Newsletter Article 04 February 2013 Pages: 3 - 3

11. Azathioprine interaction see Allopurinol

    Newsletter Article 04 February 2013 Pages: 3 - 3

12. Benzodiazepines

    Newsletter Article 04 February 2013 Pages: 3 - 4

13. Benzoyl peroxide

    Newsletter Article 04 February 2013 Pages: 4 - 4

14. Carmustine

    Newsletter Article 04 February 2013 Pages: 4 - 4

15. Cimetidine*

    Newsletter Article 04 February 2013 Pages: 4 - 4

16. Diazepam

    Newsletter Article 04 February 2013 Pages: 4 - 4

17. Diethylstilbestrol

    Newsletter Article 04 February 2013 Pages: 4 - 4

18. Droperidol

    Newsletter Article 04 February 2013 Pages: 5 - 5

19. Gold

    Newsletter Article 04 February 2013 Pages: 5 - 5

20. Halothane interaction

    Newsletter Article 04 February 2013 Pages: 5 - 5

21. Hydralazine

    Newsletter Article 04 February 2013 Pages: 5 - 5

22. Hydrocortisone

    Newsletter Article 04 February 2013 Pages: 5 - 5

23. Iodine-131

    Newsletter Article 04 February 2013 Pages: 5 - 5

24. Labetalol

    Newsletter Article 04 February 2013 Pages: 5 - 5

25. Lithium interaction

    Newsletter Article 04 February 2013 Pages: 6 - 6

26. Loxapine overdose

    Newsletter Article 04 February 2013 Pages: 6 - 6

27. Netilmicin

    Newsletter Article 04 February 2013 Pages: 6 - 6

28. Nitroglycerin overdose

    Newsletter Article 04 February 2013 Pages: 6 - 6

29. Paregoric

    Newsletter Article 04 February 2013 Pages: 6 - 6

30. Penicillamine see also Gold

    Newsletter Article 04 February 2013 Pages: 6 - 6

31. Perhexiline

    Newsletter Article 04 February 2013 Pages: 6 - 6

32. Phenytoin

    Newsletter Article 04 February 2013 Pages: 6 - 7

33. Potassium chloride overdose

    Newsletter Article 04 February 2013 Pages: 7 - 7

34. Procainamide

    Newsletter Article 04 February 2013 Pages: 7 - 7

35. Promethazine overdose

    Newsletter Article 04 February 2013 Pages: 7 - 7

36. ‘Seatone’

    Newsletter Article 04 February 2013 Pages: 7 - 7

37. Succinylcholine

    Newsletter Article 04 February 2013 Pages: 7 - 8

38. Tolmetin

    Newsletter Article 04 February 2013 Pages: 8 - 8

39. Valproic acid*

    Newsletter Article 04 February 2013 Pages: 8 - 8

40. Valproic acid interaction*

    Newsletter Article 04 February 2013 Pages: 8 - 8

41. Valproic acid overdose

    Newsletter Article 04 February 2013 Pages: 8 - 8

42. Vinblastine

    Newsletter Article 04 February 2013 Pages: 8 - 8

43. Warfarin interaction

    Newsletter Article 04 February 2013 Pages: 8 - 8

44. IM pentazocine addiction

    Newsletter Article 04 February 2013 Pages: 9 - 9

45. Analgesic nephropathy and urinary tract carcinoma

    Newsletter Article 04 February 2013 Pages: 9 - 9

46. Profound CNS depression from eucalyptus oil

    Newsletter Article 04 February 2013 Pages: 9 - 9

47. Penetration of mercury from ophthalmic preservatives into the eye

    Newsletter Article 04 February 2013 Pages: 9 - 9

48. First reports of acute mercury poisoning after polyvinyl alcohol preservative ingestion

    Newsletter Article 04 February 2013 Pages: 9 - 10

49. Household product poisoning in children is seldom serious

    Newsletter Article 04 February 2013 Pages: 10 - 10

50. Nitrosamine exposure

    Newsletter Article 04 February 2013 Pages: 10 - 10